PharmGen Science, Inc. (KRX:004720)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,615.00
+60.00 (1.32%)
At close: Aug 13, 2025, 3:30 PM KST

PharmGen Science Market Cap

PharmGen Science has a market cap or net worth of 85.10 billion as of August 14, 2025. Its market cap has decreased by -12.29% in one year.

Market Cap
85.10B
Enterprise Value
90.45B
Revenue
171.66B
Ranking
n/a
PE Ratio
722.74
Stock Price
4,615.00

Market Cap Chart

Since August 31, 1995, PharmGen Science's market cap has increased from 10.89B to 85.10B, an increase of 681.34%. That is a compound annual growth rate of 7.10%.

History

DateMarket Cap% Change
Aug 13, 202585.94B15.86%
Dec 30, 202474.18B-33.39%
Dec 28, 2023111.36B5.58%
Dec 29, 2022105.47B-33.88%
Dec 30, 2021159.51B-3.78%
Dec 30, 2020165.78B123.51%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 28, 2017 Pro Pro
Dec 29, 2016 Pro Pro
Dec 30, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Samsung Biologics 73.45T
Celltrion 38.14T
ALTEOGEN 22.98T
Yuhan 8,383.50B
SK Biopharmaceuticals 7,737.35B
PharmaResearch 7,064.96B
Peptron 6,989.21B
LigaChem Biosciences 5,419.69B
Market Cap Rankings